Atlas Trials

Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis

Clinical trial NCT01230918 · TERMINATED

Trial details

NCT number
NCT01230918
Sponsor
Ottawa Heart Institute Research Corporation
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypertrophic CardiomyopathyAcute Coronary Syndrome
Start date
2011-05-01
Primary completion
2017-04-20
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.